AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2018
Nov 6, 2018
29745_dirs_2018-11-06_b77bd182-b171-468a-b3b8-db794b56527a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-11-03
Reporting Person: Norton Johna (Senior VP, Global Quality)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-03 | Common Stock | M | 3133 | — | Acquired | 19225 | Direct |
| 2018-11-03 | Common Stock | F | 1366 | $106.75 | Disposed | 17859 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-03 | Restricted Stock Unit | $ | M | 3133 | Disposed | 2018-11-03 | Common Stock (3133.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 487 | Indirect |
| Common Stock | 34 | Indirect |
| Common Stock | 2535 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29